Parents Are Very Open to Ketamine Therapy for Kids, Study Finds
Research“As parents maintain decision-making capacity of their child’s medical care, parental consent is a key factor in the adoption of new treatments for adolescents," study authors explain.
Psychedelic Users Experienced Less Psychological Stress During COVID-19 Lockdowns, Study Finds
ResearchResearchers found stress further reduced for the participants that use psychedelic drugs at least once every six months.
FDA Authorizes Cybin Device to Quantify Psychedelics’ Effects on the Brain
Research"This study of ketamine’s psychedelic effects while wearing headgear equipped with sensors to record brain activity could open up new frontiers of understanding," says Cybin's chief clinical officer.
Psychedelics Help Heal Childhood Trauma, Study Finds
ResearchResearchers find that there were significantly lower levels of complex trauma symptoms and feelings of internalized shame in study participants that had used psychedelics therapeutically.
Psilocybin Study for Tobacco Addiction Receives First Federal Psychedelics Research Grant in 50 Years
ResearchA Johns Hopkins Medicine professor says "it was only a matter of time," while lead researcher calls the historic grant "monumental" for the psychedelics movement.
This New Company Believes Psychedelics Can Treat Dementia
ResearchThere is currently no known cure for dementia, but Return Health CEO Dr. James Kuo says psychedelics offer "unprecedented" potential.
Psychedelic Use Associated with Reduced Risk of Heart Disease and Diabetes
ResearchResearchers say there are several ways classic psychedelics could, directly and indirectly, lead to improved cardiometabolic health.
How Mindset Pharma Is Making and Defining ‘Next-Generation Psychedelic Drugs’
ResearchCEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company's lead candidate may be better than psilocybin.
World Boxing Association Partners with Psychedelics Company for TBI and PTSD Research
Research"We believe in the promise of the resurgence of psychedelic medicine and are proud to be collaborating with Lobe Sciences as we work together to improve the lives and health of members of the WBA family," says WBA president Gilberto Jesús Mendoza.
Majority of Oregon Adults Interested in Psilocybin Want to Try Microdosing
Microdosing, ResearchOn the flip side, 37% of Oregon adults surveyed said they did not know what psilocybin was.